The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · cited 1×
“Furthermore, TP-10 disrupts CAR, a well established preclinical predictor of antipsychotic activity (Wadenberg and Hicks, 1999) thought to reflect the ability of a compound to reduce stimulus salience (Kapur, 2003).”
BackgroundFunction and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203
Keefe, R. S. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.633 · Cited by 1,065
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
Institute of Laboratory Animal Resources.
Wolfle, T. L. (1995) · Cited by 620
Javitt, D. C. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78003-5 · Cited by 560
Startle response models of sensorimotor gating and habituation deficits in schizophrenia
Geyer, M. A., Swerdlow, N. R., Mansbach, R. S., & Braff, D. L. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90241-q · Cited by 454
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Inbred strain differences in prepulse inhibition of the mouse startle response
Paylor, R., & Crawley, J. N. (1997) · Psychopharmacology · doi:10.1007/s002130050333 · Cited by 379
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Immunohistochemical localization of PDE10A in the rat brain
Seeger, T. F., Bartlett, B., Coskran, T. M., Culp, J. S., James, L. C., Krull, D. L., Lanfear, J., Ryan, A. M., Schmidt, C. J., Strick, C. A., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02754-9 · Cited by 334
Self-citationSiuciak, J. A., Chapin, D. S., Harms, J. F., Lebel, L. A., McCarthy, S. A., Chambers, L., Shrikhande, A., Wong, S., Menniti, F. S., & Schmidt, C. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.013 · Cited by 278
Self-citationImmunohistochemical Localization of Phosphodiesterase 10A in Multiple Mammalian Species
Coskran, T. M., Morton, D., Menniti, F. S., Adamowicz, W. O., Kleiman, R. J., Ryan, A. M., Strick, C. A., Schmidt, C. J., & Stephenson, D. T. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a6930.2006 · Cited by 251
Self-citationArterial Stiffness and Stroke in Hypertension: Therapeutic Implications for Stroke Prevention
Laurent, S., & Boutouyrie, P. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00001 · Cited by 236
Siuciak, J. A., McCarthy, S. A., Chapin, D. S., Fujiwara, R. A., James, L. C., Williams, R. D., Stock, J. L., McNeish, J. D., Strick, C. A., Menniti, F. S., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.012 · Cited by 231
Self-citationHajós, M., Hurst, R. S., Hoffmann, W. E., Krause, M., Wall, T. M., Higdon, N. R., & Groppi, V. E. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076968 · Cited by 224
Hoffman, D. C., & Donovan, H. (1995) · Psychopharmacology · doi:10.1007/bf02246184 · Cited by 223
Preattentional and attentional cognitive deficits as targets for treating schizophrenia
Braff, D., & Light, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1848-0 · Cited by 214
Coordinated Accumbal Dopamine Release and Neural Activity Drive Goal-Directed Behavior
Cheer, J. F., Aragona, B. J., Heien, M. L. A. V., Seipel, A. T., Carelli, R. M., & Wightman, R. M. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.021 · Cited by 204
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase
Xie, Z., Adamowicz, W. O., Eldred, W. D., Jakowski, A. B., Kleiman, R. J., Morton, D. G., Stephenson, D. T., Strick, C. A., Williams, R. D., & Menniti, F. S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.042 · Cited by 198
Self-citationWadenberg, M.-L. G., & Hicks, P. B. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00037-8 · Cited by 188
Neuropharmacology of Phencyclidine: Basic Mechanisms and Therapeutic Potential
Johnson, K. M., & Jones, S. M. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003423 · Cited by 162
Henry, S., Lehmann-Masten, V., Gasparini, F., Geyer, M. A., & Markou, A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00332-5 · Cited by 146
Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats
Krause, M., Hoffmann, W. E., & Hajós, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01463-4 · Cited by 137
Ouagazzal, A., Jenck, F., & Moreau, J.-L. (2001) · Psychopharmacology · doi:10.1007/s002130100763 · Cited by 126
Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community
Mackin, P., Bishop, D. T., Watkinson, H., Gallagher, P., & Ferrier, I. N. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.031716 · Cited by 120
Ralph, R. J., Masten, V. L., Otero-Corchón, V., Low, M. J., & Geyer, M. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09604.2002 · Cited by 111
Zetterstr�m, T., Sharp, T., & Ungerstedt, U. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00505810 · Cited by 107
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105
Imre, G., Salomons, A. R., Jongsma, M. E., Fokkema, D. S., den Boer, J. A., & Horst, G. J. T. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.021 · Cited by 66
Marin, C., & Chase, T. N. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90448-q · Cited by 28
Menniti, F. S., Schmidt, C. J., & Strick, C. A. (2006) · CRC Press eBooks · doi:10.1201/9781420020847.ch12 · Cited by 10
Self-citation
Cited by
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Francis, S. H., Busch, J. L., & Corbin, J. D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002907 · Cited by 1,028
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Lakics, V., Karran, E. H., & Boess, F. G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.004 · Cited by 463
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Metadata
- Authors
- Schmidt, C. J., Chapin, D. S., Cianfrogna, J., Corman, M. L., Hajos, M., Harms, J. F., Hoffman, W. E., Lebel, L. A., McCarthy, S. A., Nelson, F. R., Proulx-LaFrance, C., Majchrzak, M. J., Ramirez, A. D., Schmidt, K., Seymour, P. A., Siuciak, J. A., Tingley, F. D., Williams, R. D., Verhoest, P. R., & Menniti, F. S.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 325
- Issue
- 2
- Pages
- 681-690
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1969601547
- Cited by
- 284
- References
- 42
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.